
Acute Respiratory Distress Syndrome (ARDS) and sepsis are critical conditions with high mortality rates. Predicting extubation failure and 30-day mortality in patients with ARDS complicated by sepsis remains challenging due to overlapping pathophysiology and dynamic clinical variables. This study aimed to develop and validate parallel prediction models for extubation failure and 30-day mortality. We extracted 934 ventilated adults with ARDS and sepsis from MIMIC-IV (2017–2019). Feature selection used LassoCV, XGBoost-RFECV, and SVM-RFECV; their intersection defined endpoint-specific features. Five models (Logistic Regression, AdaBoost, Gradient Boosting Decision Tree [GBDT], Multilayer Perceptron [MLP], and Support Vector Classification [SVC]) were developed. SMOTE and grid search were restricted to the training set, and performance was evaluated in one held-out test set with bootstrap confidence intervals. Metrics included AUC, Brier score, F1 score, and graphical calibration. Lactate and body temperature were the only predictors common to the two endpoint-specific feature sets. For extubation failure, the GBDT AUC was 0.985 in training and 0.873 in the held-out test set; the test-set AUCs for Logistic Regression and SVC were 0.887 and 0.870, respectively. For 30-day mortality, the AdaBoost AUC was 0.863 in training and 0.792 in the test set. These estimates reflect internal evaluation using a single train–test split. The two independently developed models showed preliminary internal discrimination for extubation failure and 30-day mortality. Their combined clinical value was not assessed. External validation and clinical-impact evaluation are needed before either model can be recommended for clinical use.
Assessing functional capacity is essential for risk stratification and clinical decision-making in patients with chronic obstructive pulmonary disease (COPD). The Duke Activity Status Index (DASI) is a self-administered questionnaire that estimates functional capacity, but its ability to identify functional impairment and classify patients according to established risk thresholds in COPD remains uncertain. To identify DASI cutoff points for detecting functional impairment in patients with COPD, using the six-minute walk test (6MWT), six-minute step test (6MST), and cardiopulmonary exercise testing (CPET) as reference standards, and to explore its diagnostic performance using previously established cutoff values associated with exacerbation and mortality risk. In this cross-sectional study, patients with COPD underwent the 6MWT, 6MST, and CPET. Correlations between DASI scores and performance on the functional tests were analyzed. Receiver operating characteristic (ROC) curves were used to evaluate the diagnostic performance of the DASI for identifying functional impairment and classifying patients according to previously established risk thresholds. DASI scores showed significant correlations with the 6MWT (r = 0.51), 6MST (r = 0.40), and CPET peak V̇O₂ (r = 0.36). ROC curve analysis identified optimal DASI cutoff scores ranging from 24.3 to 31.3, with acceptable diagnostic performance across the functional assessments (AUC: 0.67–0.73). The DASI demonstrated acceptable diagnostic performance for identifying functional impairment and reduced exercise capacity. These findings support its potential use as a practical screening tool to identify patients who may benefit from further objective functional evaluation. External validation of the proposed cutoff points is warranted. Not applicable.
Abstract Background The reintroduction of exercise pulmonary hypertension (EPH) to the pulmonary hypertension (PH) definition by the European guidelines underlines the importance of examining the hemodynamic response to exercise during right heart catheterization. Because the standard exercise modality of cycle ergometry (CE) is not universally accessible, we compared its hemodynamic effects with those of dynamic single-arm exercise (AE) in patients undergoing right heart catheterization (RHC). Methods 50 consecutive patients with indication for RHC were enrolled. Hemodynamic parameters were assessed at rest, followed by randomized exercise periods with an intervening rest phase. Thermodilution was used to determine cardiac output. The intensity of the AE was patient-determined, whereas CE was conducted at a fixed work rate ranging from 10 to 50 watts, based on the patient’s physical status. Oxygen uptake (VO₂) was estimated using the reverse Fick principle to compare relative exercise intensity between modalities. EPH was defined by an mPAP/cardiac output slope > 3 mmHg·L⁻¹·min⁻¹, and exercise-induced left heart disease by a rise in PAWP from ≤ 15 mmHg at rest to > 25 mmHg during exercise. Results Mean pulmonary arterial pressure increased by 12 mmHg with CE compared to 3 mmHg with AE (p<0.001), pulmonary artery wedge pressure increased by 5 mmHg versus 2 mmHg (p<0.001), cardiac output increased by 2.2 L/min versus 0.6 L/min (p<0.001) and mean pulmonary vascular resistance decreased by 0.05 WU with CE (p=0.761) and by 0.32 with AE (p=0.03). Estimated VO₂ during AE reached only 24% of the increase observed during CE, corresponding to an external workload equivalent of approximately 6 W. No patient showed an increase in pulmonary artery wedge pressure during exercise above 25mmHg to unmask left heart disease. In patients without PH at rest, CE led to the diagnosis of EPH in 5 patients while the used AE protocol was not suitable to detect EPH. Conclusion AE proved to be a safe exercise modality in our study but, with the protocol applied here, produced significantly smaller hemodynamic changes during RHC than CE and is thus not an adequate substitute in this form, leaving open whether an intensity-matched protocol could achieve comparable hemodynamic effects.
Aeroallergen sensitisation varies geographically and may be influenced by environmental and climatic factors. Understanding regional sensitisation patterns is important for allergy assessment and management. However, contemporary clinical data from the Middle Black Sea region of Türkiye are limited. This study aimed to describe aeroallergen sensitisation patterns in adults with rhinitis and/or asthma undergoing allergy evaluation and to explore their relationship with clinical phenotype and asthma severity. This retrospective cross-sectional study included 754 adults with rhinitis and/or asthma undergoing allergy evaluation who underwent skin prick testing at a tertiary allergy clinic between January 2023 and October 2024. Sensitisation profiles were analysed according to demographic characteristics, disease phenotype, and retrospectively assigned GINA treatment-step categories as a proxy for asthma severity. Multivariable multinomial logistic regression analysis was performed to evaluate the association between major aeroallergen sensitisation groups and GINA treatment-step categories, with Steps 1–2 as the reference category and adjustment for age, sex, and the other major allergen sensitisation groups. Overall, 377 patients (50.0
Unilateral absence of a pulmonary artery (UAPA), also termed unilateral pulmonary artery agenesis, is a rare congenital vascular anomaly. When it occurs in isolation it involves the right pulmonary artery in about two-thirds of cases, whereas left-sided absence is more often associated with congenital heart disease. Presentation ranges from an incidental imaging finding to hemoptysis, exertional dyspnea, recurrent infection and pulmonary hypertension. We report the case of an 18-year-old female with no prior medical history who presented with shortness of breath and hemoptysis of one-month duration. The hemoptysis was scant, consisting of blood-streaked sputum, with approximately 5–10 mL of blood expectorated over 24 h. CT pulmonary angiography showed agenesis of the right pulmonary artery with systemic supply to the right hilum through hypertrophied bronchial arteries, a hypoplastic right lung with ipsilateral parenchymal changes, and compensatory hyperinflation of the left lung. Transthoracic echocardiography showed no structural heart disease and a low echocardiographic probability of pulmonary hypertension. She was managed conservatively with bed rest, oral tranexamic acid and cough suppression and had no further episodes of hemoptysis over six months of follow-up. Congenital agenesis of the right pulmonary artery should be considered in young patients with unexplained hemoptysis, particularly in tuberculosis-endemic settings where a small, abnormal lung is easily attributed to previous infection. CT pulmonary angiography can establish the diagnosis and help distinguish it from conditions that mimic it. Echocardiographic screening for pulmonary hypertension and a defined follow-up plan should accompany the diagnosis.